M. Mestre

发表

Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.

Lydia Sánchez, Manuel Morente, Máximo Fraga, 2003, Blood.

A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples

Juan F. García, A. Sánchez-Aguilera, M. Piris, 2009, Clinical Cancer Research.

tissue-microarrays tumor suppressor pathways and cell-cycle checkpoints: analyses using Hodgkin's and Reed-Sternberg cells harbor alterations in the major

M. Piris, T. Flores, J. Menárguez, 2013 .

Hemophagocytic syndrome causing complete bone marrow failure. Report of an extreme case of a reactive histiocytic disorder.

M. Mestre, A. Garcia-Marcilla, F. J. de la Serna, 1989, Acta haematologica.

Nodular regenerative hyperplasia of the liver in renal transplantation.

L. Ruilope, J. Morales, M. Mestre, 1987, Transplantation proceedings.

p53 expression in two cases of spiradenocarcinomas.

L. Requena, M. Mestre, M. Fernández-Aceñero, 2000, The American Journal of dermatopathology.

Rhabdomyosarcoma presenting with diffuse bone marrow involvement, hypercalcemia and renal failure.

M. Mestre, J. Hornedo, M. A. Martínez, 1988, Medical and pediatric oncology.

Intrauterine candidiasis: report of four cases

M. Mestre, M. Fernández-Aceñero, T. Meizoso, 2008, Archives of Gynecology and Obstetrics.

Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place

M. Piris, M. Martínez-González, L. Sánchez-Verde, 2010, Leukemia.

ON CARDIOVASCULAR MANIFESTATIONS OF THE TOXIC OIL SYNDROME AND RELATED CONDITIONS-IV

T. N. James, M. Gómez-Sánchez, De, 2016 .

Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.

Juan F. García, A. Sánchez-Aguilera, M. Piris, 2006, Blood.

outcome of classic Hodgkin lymphoma Tumor microenvironment and mitotic checkpoint are key factors in the

Juan F. García, A. Sánchez-Aguilera, M. Piris, 2010 .

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets

Juan F. García, A. M. Martín-Moreno, I. Varela, 2017, Oncotarget.

Low-DensityArray to Predict Outcome in Advanced Hodgkin ’ s Lymphoma Using Paraffin-Embedded Samples

M. Piris, M. Fresno, M. Mestre, 2009 .

outcome of classical Hodgkin lymphoma Tumor microenvironment and mitotic checkpoint are key factors in the

L. Sánchez-Verde, M. Méndez, M. Provencio, 2006 .